Tenax Therapeutics Inc (TENX)

Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	13.34%18.78	16.57	16.45	16.81	11.79
Selling, General, and Administrative	5.93	-	-	-	-
Research and Development	11.36%12.85	11.54	10.54	10.33	6.12
Operating Income/Loss	13.34%-18.78	-16.57	-16.45	-16.81	-11.79
	13.28%-17.80	-15.72	-15.54	-15.80	-10.85
Attributable To Parent	13.28%-17.80	-15.72	-15.54	-15.80	-10.85
Basic Average Shares	12.48%50.87	45.23	0.57	39.74	39.57
Diluted Average Shares	12.48%50.87	45.23	0.57	39.74	39.57
Basic Earnings Per Share	-0.35	-0.35	-0.38	-0.40	-0.27
Diluted Earnings Per Share	-0.35	-0.35	-0.38	-0.40	-0.27